From Blood Sugar to Blood Cancer: Surprising Benefits of GLP-1s

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Looking in the Mirror: The Moth Podcast 18 min · 25 Sep 2026 · The Moth

Trump hosts President Xi at state banquet 31 min · 25 Sep 2026 · Global News Podcast

TNA Reaction: Sawyer & Shaw Arrive 18 min · 25 Sep 2026 · Busted Open

NPR News: 09-25-2026 12AM EDT 5 min · 25 Sep 2026 · NPR News Now

12AM ET 09/25/2026 Newscast 3 min · 25 Sep 2026 · Fox News Hourly Update

The Lair of the White Worm 1h 0m · 25 Sep 2026 · How Did This Get Made?

Report any issue

Source

Recorded01 May 2025

Publisherfeeds.buzzsprout.com

Handlerec:1648142

Show notes

Abhay Singh, MD, MPH, Director of the CHIP Clinic at Cleveland Clinic, joins the Cancer Advances Podcast to discuss a major new study exploring the link between GLP-1 receptor agonists and the risk of hematologic malignancies in patients with diabetes. Tune in to hear how GLP-1s, best known for managing diabetes and obesity, may hold promise for cancer prevention and what this could mean for future cardio-oncology care.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in